Barely Significant
← all excerpts

Differential clinical profile of candesartan compared to other angiotensin receptor blockers.

Vasc Health Risk Manag · 2011 · PMC3253768 · PMID 22241949

Europe PMCDOI
1
hedged sentence
0.0030
closest p · 0.1× alpha
0.0030
boldest claim

The sentences

highly significantP = 0.003actually significant
Compared with lisinopril monotherapy, dual blockade treatment caused a highly significant reduction in 24-hour PP levels (−5 ± 5 mmHg, P = 0.003), albeit the difference in the BP lowering effect between the treatment groups did not differ significantly for 24-hour SBP ( P = 0.21) or DBP ( P = 0.49).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.